A problematic Emergent vaccine plant in Maryland still lacks approval, even after FDA declared some doses produced there are safe to use.
The details are murky, but the decision to remove priority ratings under the Defense Production Act may not change much about the vaccines supply chain.
Armed with more data and real-world examples, some public health officials are renewing their calls to delay second doses
Criminals are trying to sell fake COVID-19 vaccines to desperate governments and citizens, threatening trust in the real health care supply chain.
Companies that are normally competitors are making deals to share technology and manufacturing capacity to produce enough COVID-19 vaccines.
Delaying second doses would change the distribution pattern for vaccines and reshape the supply chain. Also, vaccine manufacturers say supply is about to dramatically increase.
The public needs to be educated about the quality control processes in place for the manufacture of vaccines.
With vaccines in tow, the transportation industry will deliver a lot of much-needed holiday cheer over the next few weeks.
UPS Healthcare is increasing its capability to provide dry ice for COVID vaccine shipments while Swiss firm SkyCell is going to market with a shipping container it says is more efficient and safer because it uses less dry ice.
